BioCorRx Inc.

BioCorRx Inc. insiders are currently net buyers of BICX stock, showing bullish sentiment over the past 90 days. Executives have purchased $5.0M while selling $867.0K, resulting in a positive net flow of $4.1M. This buying activity represents 85% of total transaction volume.

BioCorRx Inc. has 9 active insiders who have filed SEC Form 4 transactions in the past 90 days. Louis C. Lucido (Executive) leads with 59 transactions totaling $4.5M. Jorge Andrade Jr (Executive) follows with 88 transactions worth $676.4K. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. BioCorRx Inc.'s current score of 85/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $5.0M in purchases versus $867.0K in sales.

The most recent insider transaction occurred on Jun 28, 2024, when Felix Lourdes (Executive) acquired 10,204 shares at $0.00 per share for $0. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, BICX insider trading sentiment is currently bullish with an Alignment Score of 85/100. The net insider flow of $4.1M reflects accumulation, with 85% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like BioCorRx Inc.. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At BICX, we track all Form 4 filings—currently showing 246 transactions from 9 insiders over 90 days.

A 10b5-1 plan allows BioCorRx Inc. executives to pre-schedule stock sales when they don't possess material non-public information. At BICX, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at BICX appears discretionary, making insider signals more meaningful.

You can monitor BioCorRx Inc. (BICX) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 9 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. BioCorRx Inc.'s current score of 85/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $5.0M in purchases versus $867.0K in sales over 90 days, resulting in a net flow of $4.1M.

SEC Form 4 filings are mandatory reports that BioCorRx Inc. insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At BICX, the most common type is "A" with 39 occurrences. The most recent Form 4 was filed on Jun 28, 2024 by Felix Lourdes.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At BioCorRx Inc., approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at BICX represents discretionary decisions with more informational value.